<?xml version="1.0" encoding="UTF-8"?>
<p>Since the vaccine targets remain undefined before an outbreak occurs, time remains one of the major hurdles for effective vaccine development. Currently, the average development time for conventional vaccines from preclinical phase is more than 10 years (
 <xref rid="B14" ref-type="bibr">14</xref>), highlighting the dire need for new approaches that allow extremely fast development and licensing to prevent an emerging outbreak from global spread.
</p>
